Download Substance Abuse In Athletes - Alcohol Medical Scholars Program

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts
no text concepts found
Transcript
Substance Use In Athletes
Woodburne O. Levy, MD
Developed for the Alcohol Medical Scholars Program
INTRODUCTION

Major problems facing sport today
– Growing attention
– Deaths of elite athletes
– Increasing attention of media

Contrary to the ethical principles of athletic
competition
 Wide spread among athletes
Developed for the Alcohol Medical
Scholars Program
2
DRUGS MISUSED BY ATHLETES
• Therapeutic drugs
– OTCs, diuretics, opioids, beta-blockers, etc.

Performance enhancing drugs
– Amphetamines, ephedrine, caffeine, anabolic
steroids, growth hormone, etc.

Drugs typically misused
– Alcohol, nicotine, marihuana, cocaine, etc.
Developed for the Alcohol Medical
Scholars Program
3
GOALS

Historical perspective
 Factors influencing athletes to use drugs
 Types of drugs athletes use- consequences
and myths
 Preventing and treating drug use in athletes
Developed for the Alcohol Medical
Scholars Program
4
Historical perspective

Ancient civilizations
– Mushrooms, herbs, liquor

19th Century
– Alcohol, caffeine, nitroglycerine, opium,
strychnine, trimethyl

World War II
– Amphetamines, testosterone
Developed for the Alcohol Medical
Scholars Program
5
Historical perspective

Post war era
– Amphetamines continue
– Anabolic steroids

Newer agents
– Blood doping
– Erythropoietin
– Growth hormone
Developed for the Alcohol Medical
Scholars Program
6
Currently prohibited by IOC

Drugs
– Stimulants, opioids, anabolic agents, diuretics,
peptide hormones

Methods
– Blood doping, artificial oxygen administration,
plasma expanders, pharmacological, chemical
and physical manipulation

In certain circumstances
– Alcohol, cannabinoids, local anesthetics, 
blockers
Developed for the Alcohol Medical
Scholars Program
7
What factors influences athletes?

Belief that competitors take drugs
 Determination to do anything to win
 Pressures from coaches, parents, peers
 Community attitudes and expectations
 Financial rewards
 Media influence
 Belief of enhanced performance
Developed for the Alcohol Medical
Scholars Program
8
THERAPEUTIC DRUGS

OTCs
– NSAIDs, laxatives, ephedrine, analgesics,
weight loss meds, corticosteroids, local
anesthetics
– Low potential for misuse
– Increased risk of further injury, GI bleed,
anemia, eating disorders
Developed for the Alcohol Medical
Scholars Program
9
THERAPEUTIC DRUGS

Diuretics
– Rapid weight loss
– Boxing, wrestling, judo
– Excretion or dilution of illegal substances
– Overall negative impact on performance
– Dehydration, hypotension, muscle cramps,
electrolyte imbalance
Developed for the Alcohol Medical
Scholars Program
10
THERAPEUTIC DRUGS

Opioids
– Prescription pain killers most common
– Allow performance while injured
– 75% used after injury only
– Increased risk of further injury, dependence,
drowsiness, mental clouding; in high doses:
respiratory depression, hypotension
Developed for the Alcohol Medical
Scholars Program
11
THERAPEUTIC DRUGS

Beta-Blockers
– Anti-tremor, anxiolytic effect
– Shooters, ski jumpers, archery
– Negative effect on endurance
– Depression, bronchospasm, fatigue
Developed for the Alcohol Medical
Scholars Program
12
PERFORMANCE ENHANCING DRUGS

CNS Stimulants
– Amphetamines
Delay fatigue, increase alertness, enhance
speed, power, endurance, concentration
– Hypertension, angina, vomiting, abdominal
pain, cerebral hemorrhage, dependence, death

Developed for the Alcohol Medical
Scholars Program
13
PERFORMANCE ENHANCING DRUGS

CNS Stimulants
– Caffeine
Shortened reaction time, improved
concentration, diuresis
 Glycogen sparing leading to delayed fatigue
 > 12 ug/mL is a positive urine per IOC
– Dyspepsia, cardiac damage, combination with
other stimulants (e.g. ephedrine) may be fatal

Developed for the Alcohol Medical
Scholars Program
14
PERFORMANCE ENHANCING DRUGS

Systemic stimulants
– Adrenalin

In local anesthetics
– Ephedrine and pseudoephedrine
 Cold and allergy remedies
– Phenylpropanolamine
 Diet pills
– Similar effects to the amphetamines in high doses
Developed for the Alcohol Medical
Scholars Program
15
PERFORMANCE ENHANCING DRUGS

Anabolic androgenic steroids
– Derivatives of testosterone
– First use generally later than other drugs
– Drug and method sought for maximum
anabolic and minimum androgenic properties
– Sprinting, weight lifting, body building
– Acne, abnormal LFTs, feminization,
virilization, premature closure of the epiphysial
plates, behavioral changes “roid rage”, CVAs,
cardiomyopathy
Developed for the Alcohol Medical
Scholars Program
16
PERFORMANCE ENHANCING DRUGS

Beta 2 agonists
– Isoproterenol, epinephrine, norepinephrine
– Sympathomimetic amines, anabolic properties
– Cardiac arrhythmias in overdose, headaches

Peptide hormones: HCG
– Increases testosterone
– Maintains testicular volume with anabolic
steroid use
– Ovarian cysts
Developed for the Alcohol Medical
Scholars Program
17
PERFORMANCE ENHANCING DRUGS

Pituitary and synthetic gonadotropins
– Increases testosterone, anti- estrogenic
– Ovarian cysts

Corticotropins
– Increase testosterone
– Rare and related to excess corticosteroids-
pituitary suppression,  immunity,
osteoporosis, hyperglycemia
Developed for the Alcohol Medical
Scholars Program
18
PERFORMANCE ENHANCING DRUGS

Growth hormone
– Increase muscle mass & decrease fat mass
– Gigantism, acromegaly, hypothyroidism,
cardiac disease, myopathies, arthritis, diabetes
mellitus, impotence, osteoporosis
Developed for the Alcohol Medical
Scholars Program
19
PERFORMANCE ENHANCING DRUGS

Erythropoietin (EPO)
– Stimulates RBC production
– Increases oxygen carrying capacity
– CVAs

Blood doping
– RBC transfusion, artificial oxygen carriers
– Increases oxygen carrying capacity
– Allergic reactions, sludging of blood
Developed for the Alcohol Medical
Scholars Program
20
FOOD SUPPLEMENTS

Viewed as legal means of gaining edge
 76-100% of athletes use vs. 50% general
population
 May or may not contribute to enhanced
performance
– Creatine, colostrum, antioxidants, sodium
bicarbonate, vitamins, proteins, amino acids
– Adverse effects not investigated
Developed for the Alcohol Medical
Scholars Program
21
TYPICAL DRUGS OF MISUSE





Most common: marijuana, cocaine, alcohol
Generally have negative effect on performance
Substance misuse same in college athletes vs. nonathletes
Decrease in use of marijuana, amphetamines and
cocaine, but increase in smokeless tobacco use,
1985-1996
Most drugs first used in junior or senior high
school (for recreation not performance)
Developed for the Alcohol Medical
Scholars Program
22
TYPICAL DRUGS OF MISUSE

Alcohol
– Most frequently used
– Negative impact on reaction time, hand-eye
coordination, balance, strength
– Excessive heat production and dehydration
– Cardiovascular and GI complications,
nutritional deficiencies, dependence
Developed for the Alcohol Medical
Scholars Program
23
TYPICAL DRUGS OF MISUSE

Cocaine
– Minimal performance enhancing effect
– Heightened arousal and increased alertness
with low doses
– Over confidence leading to increased risk of
injury
– MI, CVA, seizures, arrhythmias, dependence
Developed for the Alcohol Medical
Scholars Program
24
TYPICAL DRUGS OF MISUSE

Cannabinoids
– Most frequent illegal drug used in the US
– Male athletes have higher incidence than
non-athletic peers (opposite for females)
– Initial use in high school
– Psychomotor impairment, distorted
perception, amotivational syndrome;
decreased testosterone with long-term use
Developed for the Alcohol Medical
Scholars Program
25
TYPICAL DRUGS OF MISUSE

Nicotine
– Majority use in form of smokeless tobacco
– Males >> females
– 52% of baseball players, 26% of varsity football
players used smokeless tobacco (early 1990s
California college survey)
– Highest risk for baseball players
– Cardiovascular and pulmonary disease, oral
cancers, dependence
Developed for the Alcohol Medical
Scholars Program
26
PREVENTION AND TREATMENT

Drug testing
– Commonplace in amateur and professional
sports
– 65% of college athletes agree with testing
– 37% agreed that positive should result in
disqualification
– 67% of college athletes believe that drug testing
deters drug use
Developed for the Alcohol Medical
Scholars Program
27
DRUG PROGRAMS

Administered by leagues and associations
(NCAA, NFL, NBA)
– Responsible for relevant events, fairness,
quality of competition, safety, image of their
athletes and events
– Deter use by testing and discipline
– Some include evaluation and treatment
– Coaches can discourage use
Developed for the Alcohol Medical
Scholars Program
28
DRUG PROGRAMS

Identify individuals with drug problem to
facilitate treatment
 Keys to successful drug program:
–
–
–
–
–
–
Inclusion of all involved parties
Reliable and sensitive testing program
Consistent discipline
Evaluation of effectiveness
Confidentiality
Early prevention
Developed for the Alcohol Medical
Scholars Program
29
CHALLENGES

Most drugs not prescribed
 Viewed as essential for success
 Easy access to drugs
 Physician dilemma/role
– Monitoring side effects
– Why?, discuss pro/cons, appraisal, explore
options

Need for collaboration
Developed for the Alcohol Medical
Scholars Program
30
SUMMARY

Substance use in athletes dates to ancient
times
 Multiple factors why athletes use drugs
 Types of drugs used range from therapeutic
and performance enhancing to typical drugs
of misuse
 Programs are in place to address drug use in
athletes
Developed for the Alcohol Medical
Scholars Program
31